Akoya Biosciences, Inc. (AKYA)

Akoya Biosciences Market Cap

Akoya Biosciences has a market cap or net worth of $196.32 million as of April 16, 2024. Its market cap has decreased by -28.19% in one year.

• Market Cap: 196.32M
• Enterprise Value: 198.94M
• 1-Year Change: -28.19%
• Ranking: #3642
• Category: Micro-Cap
• Stock Price: $4.00

Market Cap Chart

Since the IPO on April 16, 2021, Akoya Biosciences's market cap has decreased from $713.79M to $196.32M, a decrease of -72.50%. That is a compound annual growth rate of -34.97%.

Market Cap History

Date	Market Cap	% Change
Apr 15, 2024	197.10M	-2.91%
Apr 12, 2024	203.00M	-3.93%
Apr 11, 2024	211.30M	-
Apr 10, 2024	211.30M	-1.58%
Apr 9, 2024	214.70M	3.52%
Apr 8, 2024	207.40M	-3.22%
Apr 5, 2024	214.30M	3.33%
Apr 4, 2024	207.40M	-2.54%
Apr 3, 2024	212.80M	-1.80%
Apr 2, 2024	216.70M	-3.30%
Apr 1, 2024	224.10M	-2.78%
Mar 28, 2024	230.50M	-0.82%
Mar 27, 2024	232.40M	2.15%
Mar 26, 2024	227.50M	-5.91%
Mar 25, 2024	241.80M	2.72%
Mar 22, 2024	235.40M	-4.00%
Mar 21, 2024	245.20M	-1.01%
Mar 20, 2024	247.70M	0.20%
Mar 19, 2024	247.20M	1.81%
Mar 18, 2024	242.80M	0.62%
Mar 15, 2024	241.30M	1.05%
Mar 14, 2024	238.80M	-0.83%
Mar 13, 2024	240.80M	0.84%
Mar 12, 2024	238.80M	0.21%
Mar 11, 2024	238.30M	-3.01%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Zevra Therapeutics	207.79M
Kodiak Sciences	203.21M
Rigel Pharmaceuticals	201.68M
Compass Therapeutics	201.43M
bluebird bio	198.52M
Cellectis	196.88M
Omeros	195.85M
Innate Pharma	195.64M